1. Home
  2. OSRH vs AEON Comparison

OSRH vs AEON Comparison

Compare OSRH & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSRH
  • AEON
  • Stock Information
  • Founded
  • OSRH N/A
  • AEON N/A
  • Country
  • OSRH United States
  • AEON United States
  • Employees
  • OSRH N/A
  • AEON N/A
  • Industry
  • OSRH
  • AEON Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSRH
  • AEON Health Care
  • Exchange
  • OSRH Nasdaq
  • AEON Nasdaq
  • Market Cap
  • OSRH 13.2M
  • AEON 13.5M
  • IPO Year
  • OSRH N/A
  • AEON N/A
  • Fundamental
  • Price
  • OSRH $0.71
  • AEON $0.93
  • Analyst Decision
  • OSRH
  • AEON Strong Buy
  • Analyst Count
  • OSRH 0
  • AEON 1
  • Target Price
  • OSRH N/A
  • AEON $7.20
  • AVG Volume (30 Days)
  • OSRH 2.0M
  • AEON 403.3K
  • Earning Date
  • OSRH 11-24-2025
  • AEON 11-12-2025
  • Dividend Yield
  • OSRH N/A
  • AEON N/A
  • EPS Growth
  • OSRH N/A
  • AEON N/A
  • EPS
  • OSRH N/A
  • AEON N/A
  • Revenue
  • OSRH $104,735.00
  • AEON N/A
  • Revenue This Year
  • OSRH N/A
  • AEON N/A
  • Revenue Next Year
  • OSRH N/A
  • AEON N/A
  • P/E Ratio
  • OSRH N/A
  • AEON N/A
  • Revenue Growth
  • OSRH N/A
  • AEON N/A
  • 52 Week Low
  • OSRH $0.45
  • AEON $0.38
  • 52 Week High
  • OSRH $13.40
  • AEON $73.44
  • Technical
  • Relative Strength Index (RSI)
  • OSRH 55.77
  • AEON 48.45
  • Support Level
  • OSRH $0.59
  • AEON $0.88
  • Resistance Level
  • OSRH $0.82
  • AEON $1.41
  • Average True Range (ATR)
  • OSRH 0.11
  • AEON 0.17
  • MACD
  • OSRH 0.02
  • AEON -0.03
  • Stochastic Oscillator
  • OSRH 51.20
  • AEON 9.76

About OSRH OSR Holdings Inc. Common Stock

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Share on Social Networks: